Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Toxicol Appl Pharmacol ; 482: 116786, 2024 01.
Artigo em Inglês | MEDLINE | ID: mdl-38086440

RESUMO

Histone deacetylase (HDAC) inhibitors diminish carcinogenesis, metastasis, and cancer cell proliferation by inducing death in cancer cells. Tissue regeneration and organ development are highly dependent on the Hippo signaling pathway. Targeting the dysregulated hippo pathway is an excellent approach for cancer treatment. According to the results of this study, the combination of panobinostat, a histone deacetylase inhibitor, and 5-fluorouracil (5-FU), a chemotherapy drug, can act synergistically to induce apoptosis in gastric cancer cells. The combination of panobinostat and 5-FU was more effective in inhibiting cell viability than either treatment alone by elevating the protein levels of cleaved PARP and cleaved caspase-9. By specifically targeting E-cadherin, vimentin, and MMP-9, the combination of panobinostat and 5-FU significantly inhibited cell migration. Additionally, panobinostat significantly increased the anticancer effects of 5-FU by activating Hippo signaling (Mst 1 and 2, Sav1, and Mob1) and inhibiting the Akt signaling pathway. As a consequence, there was a decrease in the amount of Yap protein. The combination therapy of panobinostat with 5-FU dramatically slowed the spread of gastric cancer in a xenograft animal model by deactivating the Akt pathway and supporting the Hippo pathway. Since combination treatment exhibits much higher anti-tumor potential than 5-FU alone, panobinostat effectively potentiates the anti-tumor efficacy of 5-FU. As a result, it is believed that panobinostat and 5-FU combination therapy will be useful as supplemental chemotherapy in the future.


Assuntos
Inibidores de Histona Desacetilases , Neoplasias Gástricas , Animais , Humanos , Inibidores de Histona Desacetilases/uso terapêutico , Panobinostat/farmacologia , Fluoruracila/farmacologia , Via de Sinalização Hippo , Neoplasias Gástricas/tratamento farmacológico , Proteínas Proto-Oncogênicas c-akt/farmacologia , Indóis/farmacologia , Proliferação de Células , Apoptose , Linhagem Celular Tumoral
2.
J Med Food ; 20(7): 676-684, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28598706

RESUMO

Asthma is a chronic inflammatory disease of bronchial airway, which is characterized by chronic airway inflammation, airway edema, goblet cell hyperplasia, the aberrant production of the Th2 cytokines, and eosinophil infiltration in the lungs. In this study, the therapeutic effect and the underlying mechanism of Citrus tachibana leaves ethanol extract (CTLE) in the ovalbumin (OVA)-induced allergic asthma and compound 48/80-induced anaphylaxis were investigated. Oral administration of CTLE inhibited OVA-induced asthmatic response by reducing airway inflammation, OVA-specific IgE and IgG1 levels, and increasing OVA-specific IgG2a levels. CTLE restored Th1/Th2 balance through an increase in Th2 cytokines tumor necrosis factor-α, interleukin (IL)-4, and IL-6 and decreases in Th1 cytokines interferon-γ and IL-12. Furthermore, CTLE inhibited the total level of NF-κB and the phosphorylation of IκB-α and NF-κB by OVA. In addition, CTLE dose-dependently inhibited compound 48/80-induced anaphylaxis via blocking histamine secretion from mast cells. The anti-inflammatory mechanism of CTLE may involve the modulation of Th1/Th2 imbalance via inhibiting the NF-κB signaling and histamine secretion. Taken together, we suggest that CTLE could be used as a therapeutic agent for patients with Th2-mediated or histamine-mediated allergic asthma.


Assuntos
Antiasmáticos/administração & dosagem , Asma/tratamento farmacológico , Citrus/química , Histamina/imunologia , NF-kappa B/imunologia , Extratos Vegetais/administração & dosagem , Células Th1/imunologia , Células Th2/imunologia , Animais , Antiasmáticos/isolamento & purificação , Asma/genética , Asma/imunologia , Modelos Animais de Doenças , Humanos , Imunoglobulina E/imunologia , Interleucina-12/genética , Interleucina-12/imunologia , Interleucina-6 , Camundongos , NF-kappa B/genética , Extratos Vegetais/isolamento & purificação , Células Th1/efeitos dos fármacos , Células Th2/efeitos dos fármacos
3.
Am J Chin Med ; 34(4): 601-12, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16883631

RESUMO

The effects of Korean Safflower (Carthamus tinctorius L) seed oil (SSO) on osteoporosis induced-ovariectomized rats were investigated. A total of 90 female Sprague-Dawley rats, 4-month-old, weighing 200-230 g were randomly assigned into 3 groups (30 animals/group). The animals in group I were sham operated and those of group II and III were ovariectomized (Ovx). After eight weeks, the animals of group I and II received solvent vehicle daily, whereas those of group III were administered SSO orally (1 ml/kg) daily for 30 days. The changes in the serum levels of insulin-like growth factor-I (IGF-I), IGF-II, insulin-like growth factor binding protein-3 (IGBP-3), estrogen, total alkaline phosphatase (TALP), bone-specific alkaline phosphatase (BALP), calcium and phosphorous in serum, and also the histomorphology of the proximal tibia metaphysis and femur/body weight (F/B) ratio were examined in all the groups at every 10 days interval. Thirty days later, IGF-I, IGF-II, IGBP-3 and BALP levels were significantly increased (p < 0.05) in group III as compared to groups I and II. There were no significant differences in serum levels of estrogen, TALP and F/B ratio between groups II and III, but estrogen levels were higher in group I. These results suggest that the safflower seeds have possible roles in the improvement of osteoporosis induced-ovariectomized rats.


Assuntos
Osteoporose/sangue , Ovariectomia , Óleo de Cártamo/farmacologia , Administração Oral , Fosfatase Alcalina/sangue , Animais , Cálcio/sangue , Estrogênios/sangue , Feminino , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Fator de Crescimento Insulin-Like I/metabolismo , Fator de Crescimento Insulin-Like II/metabolismo , Osteoporose/prevenção & controle , Fósforo/sangue , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Óleo de Cártamo/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA